Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Gossamer Bio, Inc. | 292,000 | reported | 14 Feb 2020 | tx 7+933,530−279,139 |
| Janux Therapeutics, Inc. | 118,889 | reported | 11 Jun 2025 | tx 8+58,864 |
| FIVE PRIME THERAPEUTICS INC | 10,000 | reported | 10 May 2018 | tx 4+55,000 |
| Turning Point Therapeutics, Inc. | 8,500 | reported | 15 Jun 2020 | tx 2+23,500 |
| Ventyx Biosciences, Inc. | 0 | reported | 04 Mar 2026 | tx 22+744,901−1,526,956 |
| Receptos, Inc. | 0 | reported | 27 Aug 2015 | tx 12+210,651−504,645 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Mar 2026 | OTHER | Ventyx Biosciences, Inc. | 130,000 | — | |
| 04 Mar 2026 | OTHER | Ventyx Biosciences, Inc. | 662,369 | — | deriv |
| 04 Mar 2026 | OTHER | Ventyx Biosciences, Inc. | 277,941 | — | deriv |
| 04 Mar 2026 | OTHER | Ventyx Biosciences, Inc. | 80,000 | — | deriv |
| 04 Mar 2026 | OTHER | Ventyx Biosciences, Inc. | 40,000 | — | deriv |
| 04 Mar 2026 | OTHER | Ventyx Biosciences, Inc. | 33,000 | — | deriv |
| 04 Mar 2026 | OTHER | Ventyx Biosciences, Inc. | 21,825 | — | deriv |
| 04 Mar 2026 | OTHER | Ventyx Biosciences, Inc. | 15,937 | — | deriv |
| 11 Jun 2025 | GRANT_AWARD | Janux Therapeutics, Inc. | 3,750 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | Janux Therapeutics, Inc. | 11,667 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Ventyx Biosciences, Inc. | 40,000 | 0.00 USD | deriv |
| 23 Dec 2024 | PURCHASE | Ventyx Biosciences, Inc. | 130,000 | 2.31 USD | first after silence |
| 05 Nov 2024 | OTHER | Janux Therapeutics, Inc. | 4,611 | 0.00 USD | |
| 26 Jun 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 2,500 | 0.00 USD | |
| 26 Jun 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 8,350 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Ventyx Biosciences, Inc. | 33,000 | 0.00 USD | deriv |
| 29 Feb 2024 | OTHER | Janux Therapeutics, Inc. | 2,986 | 0.00 USD | |
| 21 Jan 2024 | GRANT_AWARD | Ventyx Biosciences, Inc. | 80,000 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Janux Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | Ventyx Biosciences, Inc. | 15,937 | 0.00 USD | deriv |
| 30 Mar 2023 | SALE | Ventyx Biosciences, Inc. | 100,000 | 33.73 USD | |
| 30 Mar 2023 | EXERCISE | Ventyx Biosciences, Inc. | 100,000 | 6.03 USD | |
| 30 Mar 2023 | EXERCISE | Ventyx Biosciences, Inc. | 100,000 | 0.00 USD | deriv |
| 21 Dec 2022 | GIFT | Ventyx Biosciences, Inc. | 32,987 | 0.00 USD | |
| 14 Jun 2022 | GRANT_AWARD | Janux Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 23 Dec 2024.